超声诊断药物性胆结石的临床意义

目的分析超声诊断药物性胆结石的临床价值.方法：选取 2016 年 1 月-2017 年 12 月 100 例首次发现胆囊结石的患者作为观察对象,并应用超声观察胆囊大小、形态以及结石数目、大小、回声等方面的情况,并询问患者近期药物复用史,同时在一个月、两个月、三个月内复查胆结石状况.结果：100 例患者中有 46 例近期服用过头孢类药物,其中有 17 例在一个月内胆结石消失,1例在两个月内胆结石消失,三个月后复诊发现与之前相比无硬化迹象.结论：头孢类药物服用患者可能出现胆囊结石,声像图与普通胆结石患者无明显差异,在临床诊断中需要详细询问患者的病史,并叮嘱患者定期复诊从而选择合适的治疗方案.

Objective： To analyze the clinical value of ultrasound in diagnosing drug-induced gallstones. Methods： From January 2016 to December 2017, 100 patients with gallbladder stones were firstly observed as subjects. Ultrasound was used to observe the gallbladder size, morphology, number of stones, size, echo, etc., and the patient was asked about the recent drug recovery. Using history, review gallstone status within one month, two months, and three months at the same time. RESULTS： Among the 100 patients, 46 cases had recently taken cephalosporins, of which 17 cases had gallstones disappeared in one month and 1 case disappeared within 2 months. After 3 months, they did not have any comparison with previous cases. Hardening signs. Conclusion： Patients with cephalosporins may develop cholecystolithiasis. There is no significant difference between the sonogram and common gallstones. In clinical diagnosis, it is necessary to ask the patient＇s history in detail and ask the patient to return to the clinic regularly to select the appropriate treatment plan.